Therapeutic Goods (Medical Devices) Regulations 2002

Administered by Department of Health, Disability and Ageing

Legislation au F2002B00237 Regulations In force Legislative Instrument

Legislation content

Therapeutic Goods (Medical Devices) Regulations 2002

Statutory Rules No. 236, 2002

made under the

Therapeutic Goods Act 1989

Compilation No. 71

Compilation date: 1 July 2026

Includes amendments: F2026L00847

About this compilation

This compilation

This is a compilation of the Therapeutic Goods (Medical Devices) Regulations 2002 that shows the text of the law as amended and in force on 1 July 2026 (the compilation date).

The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.

Uncommenced amendments

The effect of uncommenced amendments is not shown in the text of the compiled law. The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. Any uncommenced amendments affecting the law are accessible on the Register (www.legislation.gov.au).

Application, saving and transitional provisions

If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.

Editorial changes

For more information about any editorial changes made in this compilation, see the endnotes.

Presentational changes

The Legislation Act 2003 provides for First Parliamentary Counsel to make presentational changes to a compilation. Presentational changes are applied to give a more consistent look and feel to legislation published on the Register, and enable the user to more easily navigate those documents.

Modifications

If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. Any modifications affecting the law are accessible on the Register.

Self‑repealing provisions

If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.

 

 

   

Contents

Part 1—Preliminary

1.1 Name of Regulations

1.3 Definitions—the dictionary etc

1.4 Medical devices with a measuring function

1.5 Refurbishment (Act s 3(1))

1.6 Kinds of medical devices—other common characteristics (Act s 41BE(1)(e))

1.7 Device nomenclature system codes (Act s 41BE(3))

1.8 Classes of persons that are not manufacturers of a medical device

Part 2—Essential principles

2.1 Essential principles (Act s 41CA)

Part 3—Conformity assessment procedures

Division 3.1—Medical device classifications

3.1 Medical device classifications (Act s 41DB)

3.2 Classification of medical devices

3.3 Principles for applying the classification rules

Division 3.2—Conformity assessment procedures

3.4 Conformity assessment procedures (Act s 41DA)

3.5 Powers and functions of Secretary in relation to conformity assessment

3.6 Class III medical devices (other than medical devices used for a special purpose)

3.6A Class 4 IVD medical devices (other than medical devices to be used for a special purpose)

3.6B Class 4 in‑house IVD medical devices (other than medical devices to be used for a special purpose)

3.7 Class IIb medical devices (other than medical devices used for a special purpose)

3.7A Class 3 IVD…

Overview

The Therapeutic Goods (Medical Devices) Regulations 2002 were enacted to provide a comprehensive regulatory framework for the regulation of medical devices in Australia. The regulations were made under the Therapeutic Goods Act 1989 by the Australian Government and address the need for stringent oversight and control over the safety, efficacy, and quality of medical devices available in the market. The policy objective of these regulations is to ensure that medical devices meet essential health and safety standards, thereby protecting public health. The regulations cover a wide range of aspects including the classification of medical devices, conformity assessment procedures, the inclusion of medical devices in the Australian Register of Therapeutic Goods, and the responsibilities of manufacturers and importers. The aim is to facilitate the availability of safe and effective medical devices while preventing the entry of substandard or unsafe devices into the market.

Scope and Application

The Therapeutic Goods (Medical Devices) Regulations 2002, as amended, apply to all medical devices intended for use in Australia, regulating their classification, conformity assessment, and registration processes. These regulations fall under the Therapeutic Goods Act 1989 and govern the manufacturing, importation, supply, and export of medical devices. They apply to all entities and individuals involved in the production, importation, supply, and distribution of medical devices in Australia. The regulations establish a classification system for medical devices based on their risk level, ranging from Class I (low risk) to Class IV (high risk). Conformity assessment procedures, including quality management systems and clinical evaluation, are mandated for different classes of medical devices. The regulations also detail the requirements for obtaining conformity assessment certificates and listing devices on the Australian Register of Therapeutic Goods. Certain medical devices and classes are exempt from specific requirements, such as those used in life-threatening situations or for experimental purposes under strict controls. The regulations are enforced by the Therapeutic Goods Administration, and failure to comply can result in penalties or legal action. Transitional provisions are included to accommodate devices already in circulation before the regulations came into effect, ensuring a smooth implementation process. The scope and application of these regulations are further refined through subordinate instruments, which provide additional guidelines and specific amendments to the primary legislation.

Key Provisions

  • The Therapeutic Goods (Medical Devices) Regulations 2002 outline several key provisions regarding medical devices in Australia. Firstly, these Regulations specify the classification of medical devices, the essential principles for their safety and performance, and the conformity assessment procedures that manufacturers must follow. They also detail the obligations for manufacturers to ensure their devices meet these essential principles and are appropriately classified. For example, Regulation 3.1 mandates that medical devices be classified based on their intended use and risk level, while Regulation 2.1 sets forth the essential principles that all devices must meet, such as ensuring they do not compromise health and safety and are suitable for their intended purpose. Manufacturers are required to provide detailed information about their devices, including clinical evidence, as stated in Regulation 14. Additionally, these Regulations establish the process for obtaining conformity assessment certificates, which are necessary for placing certain medical devices on the market. Regulation 4.2, for instance, details the procedures for issuing these certificates.
  • The Regulations impose various obligations on manufacturers and other entities involved in the medical device industry. Manufacturers must classify their devices correctly (Regulation 3.1), ensure they meet the essential principles outlined in Schedule 1 (Regulation 2.1), and provide detailed records and documentation in English (Regulation 3.12). Furthermore, manufacturers are required to maintain records of their manufacturing processes and submit them for review by the Secretary (Regulation 4.13). For medical devices intended for special purposes, additional requirements apply, such as the need for specific clinical evidence and adherence to unique conformity assessment procedures (Regulations 7.1 to 7.8). These obligations ensure that medical devices entering the Australian market are safe and effective.
  • Breach of these Regulations can lead to significant civil and criminal consequences. For example, failure to notify the Secretary of adverse events within the specified periods can result in strict liability offences and civil penalties (Regulations 10.4 and 10.4A). Regulation 10.4 imposes an offence with a penalty of up to 10 penalty units for not notifying adverse events within the required timeframe, while Regulation 10.4A imposes a civil penalty for similar breaches. Additionally, non-compliance with record-keeping requirements or providing false information can lead to further penalties, as detailed in the Therapeutic Goods Act 1989. These provisions underscore the importance of adherence to the Regulations to avoid legal repercussions.

Legal classification tags

Area of Law
Medical Law
Regulatory Law
Instrument
Regulation
Concepts
Definitions & Interpretation
Compliance Obligations
Reporting & Disclosure Obligations
Regulatory Standards
Licensing & Registration
Conformity Assessment Procedures
Exemptions & Exclusions
CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Therapeutic Goods (Medical Devices) Regulations 2002 and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Citations

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.